- Home
- GOSS vs SPIR Comparison
GOSS vs SPIR Comparison
Compare GOSS & SPIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- SPIR
- Stock Information
- Founded
- GOSS 2015
- SPIR 2012
- Country
- GOSS United States
- SPIR United States
- Employees
- GOSS N/A
- SPIR N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- SPIR Telecommunications Equipment
- Sector
- GOSS Health Care
- SPIR Consumer Discretionary
- Exchange
- GOSS Nasdaq
- SPIR Nasdaq
- Market Cap
- GOSS 347.8M
- SPIR 363.0M
- IPO Year
- GOSS 2019
- SPIR N/A
- Fundamental
- Price
- GOSS $1.96
- SPIR $9.11
- Analyst Decision
- GOSS Strong Buy
- SPIR Strong Buy
- Analyst Count
- GOSS 4
- SPIR 5
- Target Price
- GOSS $8.50
- SPIR $16.75
- AVG Volume (30 Days)
- GOSS 3.2M
- SPIR 615.4K
- Earning Date
- GOSS 08-05-2025
- SPIR 08-13-2025
- Dividend Yield
- GOSS N/A
- SPIR N/A
- EPS Growth
- GOSS N/A
- SPIR N/A
- EPS
- GOSS N/A
- SPIR N/A
- Revenue
- GOSS $40,237,000.00
- SPIR $99,502,000.00
- Revenue This Year
- GOSS N/A
- SPIR N/A
- Revenue Next Year
- GOSS $63.97
- SPIR $5.92
- P/E Ratio
- GOSS N/A
- SPIR N/A
- Revenue Growth
- GOSS N/A
- SPIR N/A
- 52 Week Low
- GOSS $0.66
- SPIR $6.26
- 52 Week High
- GOSS $2.23
- SPIR $21.43
- Technical
- Relative Strength Index (RSI)
- GOSS 58.35
- SPIR 38.59
- Support Level
- GOSS $1.67
- SPIR $9.40
- Resistance Level
- GOSS $2.00
- SPIR $11.28
- Average True Range (ATR)
- GOSS 0.17
- SPIR 0.59
- MACD
- GOSS -0.02
- SPIR -0.01
- Stochastic Oscillator
- GOSS 52.21
- SPIR 6.69
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About SPIR Spire Global Inc.
Spire Global Inc is a provider of space-based data, analytics, and Space Services, offering datasets and powerful insights about Earth from the ultimate vantage point of space so that organizations can make decisions with confidence, accuracy, and speed. It generates revenue from four solutions: Maritime, Aviation, Weather, and Space Services. It offers the following three data solutions to customers; Maritime-precise space-based data used for accurate ship monitoring, ship safety, and route optimization, Aviation-precise space-based data used for accurate aircraft monitoring, aircraft safety, and route optimization, and Weather-precise space-based data used for accurate weather forecasting.